The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Category: City University of New York
-
Embattled Alzheimer’s Researcher Is Charged With Fraud
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
-
AI Program Aims to Break Barriers for Female Students
A new program, backed by Cornell Tech, M.I.T. and U.C.L.A., helps prepare lower-income, Latina and Black female computing majors for artificial intelligence careers.
-
CUNY Halts Investigation of Alzheimer’s Researcher
Citing questions about the integrity of the process, the university said that “no final action” had been taken.
-
Scientists Investigating Alzheimer’s Drug Faulted in Leaked Report
A professor at the City College of New York engaged in “significant research misconduct,” an investigating committee concluded.
-
CUNY Graduates With Tech Degrees Struggle to Land Tech Jobs
The New York Times – Business:Students at the City University of New York are increasingly graduating with degrees in technology. A new report details the obstacles they face in landing jobs.